However, given the estimated 5% prevalence of slowly evolving autoimmune type 1 diabetes masking as type 2 diabetes, standardised measurement of autoantibodies may enable insulin-insufficient individuals to be identified, avoiding undue delays in insulin initiation [40, 41]. This evidence concerns the gene INS and type 2 diabetes mellitus.